Clinical impact of PET/MR in treated colorectal cancer patients.

Barbara J AmorimTheodore S HongLawrence S BlaszkowskyCristina R FerroneDavid L BergerLiliana G BordeianouRocco RicciardiJeffrey W ClarkDavid P RyanJennifer Y WoMotaz QadanMark VangelLale UmutluDavid GrosharLina G CañamaquesDebra A GervaisUmar MahmoodBruce R RosenOnofrio Antonio Catalano

Published in: European journal of nuclear medicine and molecular imaging (2019)

PET/MR is a promising imaging tool in the evaluation of treated CRC and might change the management in these patients. However, multicenter prospective studies with larger patient samples are required in order to confirm these preliminary results.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
peritoneal dialysis
computed tomography
magnetic resonance
high resolution
positron emission tomography
magnetic resonance imaging
case report
double blind